We may well be on a cross purpose , the Phase I is hugely Valuable ,, 1st it showed that MPL was Tolerable and Soluble and a beneficial dose could make it across the Blood Brain Barrier , that beneficial dose obviously had a positive effect on a Degenerative Disease MND.
Its the level of statistics gathered from only 12 Patients ,,, is that enough to satisfy the FDA to make an informed decision to approve MPL "Pharmapantel" for global use?
Well we are all about to find out,,,very soon...NZT
On the funding the ASX regulation is the Company must have 2 X Q operating Capital , so funds must be raised and banked in the next 77 days.
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1374
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.55M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $330.4K | 1.741M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4071 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 24580 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |